Ftse Mib
33.707,21
-0,38%
DAX
18.177,62
-0,90%
S&P 500
5.469,30
0,39%
NASDAQ
17.717,65
1,26%
Bitcoin
61.780,47
-0,04%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Diffusion Pharmaceuticals Inc (DFFN) Diffusion Pharmaceuticals Inc (DFFN) Notizie

DFFN

Diffusion Pharmaceuticals (DFFN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DFFN
DataOraFonteTitoloSimboloCompagnia
15/06/202400:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DFFNDiffusion Pharmaceuticals Inc
14/06/202422:09Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:DFFNDiffusion Pharmaceuticals Inc
14/06/202422:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DFFNDiffusion Pharmaceuticals Inc
06/06/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DFFNDiffusion Pharmaceuticals Inc
30/05/202423:18Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:DFFNDiffusion Pharmaceuticals Inc
14/05/202422:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DFFNDiffusion Pharmaceuticals Inc
10/05/202423:09Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:DFFNDiffusion Pharmaceuticals Inc
29/04/202422:06Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:DFFNDiffusion Pharmaceuticals Inc
12/04/202401:55Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:DFFNDiffusion Pharmaceuticals Inc
29/03/202421:02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:DFFNDiffusion Pharmaceuticals Inc
06/03/202422:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DFFNDiffusion Pharmaceuticals Inc
09/02/202423:02Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:DFFNDiffusion Pharmaceuticals Inc
09/02/202422:31Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:DFFNDiffusion Pharmaceuticals Inc
29/09/202322:21Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DFFNDiffusion Pharmaceuticals Inc
29/09/202322:01Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:DFFNDiffusion Pharmaceuticals Inc
15/08/202322:01GlobeNewswire Inc.Diffusion Pharmaceuticals Stockholders Approve Merger with EIP PharmaNASDAQ:DFFNDiffusion Pharmaceuticals Inc
14/08/202322:16Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:DFFNDiffusion Pharmaceuticals Inc
23/06/202312:03Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:DFFNDiffusion Pharmaceuticals Inc
19/05/202322:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DFFNDiffusion Pharmaceuticals Inc
15/05/202323:20Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:DFFNDiffusion Pharmaceuticals Inc
15/05/202314:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DFFNDiffusion Pharmaceuticals Inc
11/05/202312:05Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:DFFNDiffusion Pharmaceuticals Inc
03/04/202323:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DFFNDiffusion Pharmaceuticals Inc
30/03/202313:00GlobeNewswire Inc.EIP Pharma and Diffusion Pharmaceuticals Announce Merger Agreement to Create Leading CNS-focused Company Treating Neurodegenerative DiseasesNASDAQ:DFFNDiffusion Pharmaceuticals Inc
24/03/202321:06Edgar (US Regulatory)Annual Report (10-k)NASDAQ:DFFNDiffusion Pharmaceuticals Inc
16/12/202223:17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:DFFNDiffusion Pharmaceuticals Inc
16/12/202212:30GlobeNewswire Inc.Diffusion Pharmaceuticals Announces Agreement with LifeSci Special OpportunitiesNASDAQ:DFFNDiffusion Pharmaceuticals Inc
06/12/202214:31Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prrn14a)NASDAQ:DFFNDiffusion Pharmaceuticals Inc
05/12/202212:30GlobeNewswire Inc.Diffusion Pharmaceuticals Sends Letter to Stockholders Highlighting Strength of Board Leadership and Positive Progress in Strategic Review, Cautioning Stockholders Regarding LifeSci’s History of Stockholder Value Destruction and Self-DealingNASDAQ:DFFNDiffusion Pharmaceuticals Inc
23/11/202217:27Edgar (US Regulatory)Proxy Statement - Contested Solicitations (preliminary) (prec14a)NASDAQ:DFFNDiffusion Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DFFN

La tua Cronologia

BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
SPM
Saipem
BIT
LDO
Leonardo
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BPE
Bper Banca
BIT
RACE
Ferrari NV
BIT
FCTAAW
Fincantieri
BIT
SRG
Snam
BIT
TEN
Tenaris
BIT
FCT
Fincantieri
BIT
BAMI
Banco BPM
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network